HIDE, M.; PARK, H.-S.; IGARASHI, A.; YE, Y.-M.; KIM, T.-B.; YAGAMI, A. Efficacy and Safety of Omalizumab in Japanese and Korean Patients with Chronic Idopathic/Spontaneous Urticaria (CIU/CSU: Results from the Phase 3 POLARIS Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s126, 2017. DOI: 10.25251/skin.1.supp.125. Disponível em: https://jofskin.org/index.php/skin/article/view/185. Acesso em: 3 jul. 2024.